ArriVent BioPharma, Inc. – Trademark Portfolio
Entity Type: 03
ArriVent BioPharma, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include A and ARRIVENT. The owner is based in Newtown Square, PA.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073-3269
Showing of trademarks Trademarks
Trademark Classifications
ArriVent BioPharma, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ArriVent BioPharma, Inc. have?
ArriVent BioPharma, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 1 abandoned.
What trademark classes does ArriVent BioPharma, Inc. file in?
ArriVent BioPharma, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ArriVent BioPharma, Inc.'s most well-known trademarks?
ArriVent BioPharma, Inc.'s registered trademark portfolio includes well-known marks such as A and ARRIVENT. These are among 3 currently registered trademarks in the portfolio.
What is ArriVent BioPharma, Inc.'s trademark registration success rate?
ArriVent BioPharma, Inc. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.